Octapharma USA, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$17.6M
Doctors Paid
7,638
Transactions
23,074
2024 Total
$1.8M
Payment Breakdown by Category
Research$13.7M (77.8%)
Travel$651,481 (3.7%)
Food & Beverage$622,832 (3.5%)
Consulting$140,954 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.7M | 1,888 | 77.8% |
| Honoraria | $1.2M | 434 | 6.6% |
| Grant | $885,287 | 10 | 5.0% |
| Travel and Lodging | $651,481 | 1,239 | 3.7% |
| Food and Beverage | $622,832 | 19,300 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,220 | 15 | 2.5% |
| Consulting Fee | $140,954 | 154 | 0.8% |
| Education | $3,150 | 34 | 0.0% |
Payments by Type
Research
$13.7M
1,888 transactions
General
$3.9M
21,186 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Von Willebrand Factor in Pregnancy (VIP) Study | $2.0M | 0 | 2 |
| GAM10-10 | $1.2M | 3 | 67 |
| NGAM-13 | $1.2M | 8 | 106 |
| INdividualized ITI based on fviii ATE protection by vwf INITIATE | $1.1M | 0 | 1 |
| GAM5-28 | $1.0M | 2 | 331 |
| LEX-211 | $1.0M | 4 | 30 |
| GAM10-08 | $880,249 | 8 | 204 |
| SCGAM-06 | $683,480 | 7 | 178 |
| LEX-209 | $452,610 | 11 | 196 |
| NORM-01 | $383,258 | 1 | 70 |
| NGAM-12 | $348,562 | 4 | 117 |
| LEX-210 | $329,999 | 1 | 35 |
| Von Willebrand Factor in Pregnancy | $329,662 | 0 | 8 |
| SCGAM-03 | $319,159 | 4 | 51 |
| NGAM-10 | $241,150 | 3 | 77 |
| SCGAM-01 | $193,594 | 0 | 32 |
| LAS-215 | $176,936 | 3 | 31 |
| LAS-213 | $161,157 | 5 | 45 |
| CUTAQUIG REGISTRY | $151,582 | 0 | 3 |
| Gena-21b | $120,638 | 0 | 45 |
| Cutaquig Registry | $119,129 | 0 | 1 |
| Gena-05 | $118,264 | 0 | 29 |
| PPH STUDY | $114,955 | 0 | 3 |
| ATN-106 | $105,448 | 1 | 9 |
| GENA-21b | $102,902 | 0 | 16 |
| LAS-212 | $86,005 | 4 | 24 |
| PANS STUDY | $81,078 | 0 | 2 |
| NGAM-11 | $67,223 | 7 | 18 |
| OCTAPLAS IIS STUDY | $62,165 | 0 | 4 |
| GENA-05 | $52,387 | 5 | 30 |
Payments by Medical Specialty
Top Paid Doctors — Page 8
| Doctor | Specialty | Location | Total | 2018 |
|---|---|---|---|---|
| Eric Mullins, Md, MD | Pediatric Hematology-Oncology | Cincinnati, OH | $3,545 | $0 |
| Vivek Sharma, Md, MD | Hematology & Oncology | Louisville, KY | $3,530 | $0 |
| Maryam Sarraf Yazdy | Internal Medicine | Washington, DC | $3,528 | $0 |
| Dr. Jennifer Brown, Md Phd, MD PHD | Internal Medicine | Boston, MA | $3,500 | $0 |
| Unknown Provider | — | — | $3,500 | $0 |
| Dr. Annette Von Drygalski, Md, MD | Hematology & Oncology | San Diego, CA | $3,500 | $0 |
| Dr. Eric Grabowski, Md Scd, MD SCD | Pediatrics | Boston, MA | $3,435 | $0 |
| Dr. Cindy Leissinger | Specialist | New Orleans, LA | $3,418 | $0 |
| Dr. Douglass Drelich, M.d, M.D | Hematology | Philadelphia, PA | $3,351 | $0 |
| Jordan Shavit, Md, MD | Pediatrics | Ann Arbor, MI | $3,272 | $0 |
| Dr. Stephanie Fritch Lilla, Md, MD | Pediatric Hematology-Oncology | Minneapolis, MN | $3,263 | $0 |
| Dr. Cristina Tarango, M.d, M.D | Pediatric Hematology-Oncology | Cincinnati, OH | $3,157 | $0 |
| Dr. Steven Fein, M.d, M.D | Hematology & Oncology | Miami, FL | $3,121 | $0 |
| Dhiman Basu, Md, MD | Internal Medicine | Colleyville, TX | $3,085 | $0 |
| Dr. Susan Swedo, M.d, M.D | Pediatrics | Bethesda, MD | $3,000 | $0 |
| Gordon Myers, M.d, M.D | Allergy & Immunology | Cincinnati, OH | $2,992 | $0 |
| Dr. Diane Nugent, M.d, M.D | Pediatric Hematology-Oncology | Orange, CA | $2,918 | $0 |
| Krysten Sargenton, Arnp Bc, ARNP BC | Nurse Practitioner | Miami, FL | $2,913 | $0 |
| Dr. Alan Koterba, M.d, M.D | Internal Medicine | North Palm Beach, FL | $2,913 | $0 |
| Dr. Joshua Jacobs, Md, MD | Allergy & Immunology | Walnut Creek, CA | $2,905 | $0 |
| Kelly Bellm, Aprn, APRN | Pediatrics | Nashville, TN | $2,892 | $0 |
| Unknown Provider | — | — | $2,886 | $0 |
| Dr. Yu-Min Shen, Md, MD | Hematology & Oncology | Dallas, TX | $2,861 | $0 |
| Mrs. Sofia Miranda, Arnp-Bc, ARNP-BC | Pediatrics | Miami, FL | $2,765 | $0 |
| Ramesh Kesavalu, M.d, M.D | Rheumatology | Glendale, CA | $2,611 | $0 |
Ad
Top Products
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.4M
Associated Products (14)
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.8M
- PANZYGA $2.5M
- WILATE $2.0M
- CUTAQUIG $1.6M
- OCTAGAM $1.4M
- NUWIQ $1.1M
- OCTAPLAS $560,635
- FIBRYGA $418,333
- OCTAPLEX $400,900
- OCTANORM $341,872
- CUTAQUIQ $82,876
- BALFAXAR $49,885
- IVIG $29,114
Payment Categories
- Food & Beverage $622,832
- Consulting $140,954
- Travel & Lodging $651,481
- Research $13.7M
About Octapharma USA, Inc.
Octapharma USA, Inc. has made $17.6M in payments to 7,638 healthcare providers, recorded across 23,074 transactions in the CMS Open Payments database. In 2024, the company paid $1.8M. The top product by payment volume is WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) ($2.9M).
Payments were distributed across 166 medical specialties. The top specialty by payment amount is Pediatric Hematology-Oncology ($603,018 to 125 doctors).
Payment categories include: Food & Beverage ($622,832), Consulting ($140,954), Research ($13.7M), Travel & Lodging ($651,481).
Octapharma USA, Inc. is associated with 14 products in the CMS Open Payments database, including WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN), OCTAGAM IMMUNE GLOBULIN (HUMAN), and PANZYGA.